Correlation Between Gilead Sciences and Takeda Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Gilead Sciences and Takeda Pharmaceutical Co, you can compare the effects of market volatilities on Gilead Sciences and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and Takeda Pharmaceutical.

Diversification Opportunities for Gilead Sciences and Takeda Pharmaceutical

-0.81

Correlation Coefficient

Gilead Sciences  Takeda Pharmaceutical

Pay attention - limited upside

The 3 months correlation between Gilead and Takeda is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and Takeda Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and Takeda Pharmaceutical go up and down completely randomly.

Pair Corralation between Gilead Sciences and Takeda Pharmaceutical

Given the investment horizon of 90 days Gilead Sciences is expected to generate 1.58 times more return on investment than Takeda Pharmaceutical. However, Gilead Sciences is 1.58 times more volatile than Takeda Pharmaceutical Co. It trades about 0.19 of its potential returns per unit of risk. Takeda Pharmaceutical Co is currently generating about -0.12 per unit of risk. If you would invest  7,827  in Gilead Sciences on August 30, 2024 and sell it today you would earn a total of  1,414  from holding Gilead Sciences or generate 18.07% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Gilead Sciences  vs.  Takeda Pharmaceutical Co

Gilead Sciences

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Gilead Sciences are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain essential indicators, Gilead Sciences exhibited solid returns over the last few months and may actually be approaching a breakup point.

Takeda Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Takeda Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Pair Trading with Gilead Sciences and Takeda Pharmaceutical

The main advantage of trading using opposite Gilead Sciences and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.

The idea behind Gilead Sciences and Takeda Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.